Complicaciones crónicas de la diabetes mellitus tipo 1

  1. J. Boris Quiñones Silva 1
  2. A. Bayona Cebada 2
  3. Héctor Francisco Escobar Morreale 3
  4. Lía Nattero Chávez 4
  1. 1 Unidad de Diabetes, Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España
  2. 2 Unidad de Diabetes, Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Grupo de Investigación en Diabetes, Obesidad y Reproducción Humana integrado en el CIBER de Diabetes y Enfermedades Metabólicas, Instituto de Salud Carlos III, Madrid, España Universidad de Alcalá, Alcalá de Henares, Madrid, España
  3. 3 Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Grupo de Investigación en Diabetes, Obesidad y Reproducción Humana integrado en el CIBER de Diabetes y Enfermedades Metabólicas, Instituto de Salud Carlos III, Madrid, España Universidad de Alcalá, Alcalá de Henares, Madrid, España
  4. 4 Unidad de Diabetes, Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España Grupo de Investigación en Diabetes, Obesidad y Reproducción Humana integrado en el CIBER de Diabetes y Enfermedades Metabólicas, Instituto de Salud Carlos III, Madrid, España
Mostrar afiliaciones +
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2024

Título del ejemplar: Enfermedades endocrinológicas y metabólicas (VI): Diabetes mellitus (I)

Serie: 14

Número: 18

Páginas: 1064-1071

Tipo: Artículo

DOI: 10.1016/J.MED.2024.10.003 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

Type 1 diabetes mellitus (DM1) is a chronic disease that predisposes individuals to multiple microangiopathic and macrovascular complications. Microangiopathic complications include diabetic retinopathy, diabetic neuropathy, and diabetic nephropathy, while macrovascular complications include coronary artery disease, cerebrovascular disease, and peripheral artery disease. This update reviews the prevalence, pathogenesis, forms of presentation, diagnosis, and treatment of these complications, emphasizing the importance of screening and early management to prevent progression and improve patients’ quality of life.

Referencias bibliográficas

  • 1. F. Gómez-Peralta et al. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study. Endocrinol Diabetes Nutr. (2021)
  • 2. T.H.M. Fung et al. Diabetic retinopathy for the non-ophthalmologist. Clinical Medicine. (2022)
  • 3. D. Selvarajah et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. (2019)
  • 4. M.A. Elafros et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. (2022)
  • 5. I.H. de Boer et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. (2022)
  • 6. D.P. Murray et al. Is dietary protein intake predictive of 1-year mortality in dialysis patients? Am J Med Sci. (2018)
  • 7. W.K. Al-Delaimy et al. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med. (2004)
  • 8. N.J. Morrish et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. (2001)
  • 9. D.S. Fong et al. Diabetic retinopathy. Diabetes Care. (2004)
  • 10. H. Sharma et al. Cardiovascular disease in type 1 diabetes. Cardiovasc Endocrinol Metab. (2019)
  • 11. R.W. Jansson et al. Diabetic retinopathy in type 1 diabetes patients in Western Norway. Acta Ophthalmol. (2018)
  • 12. D.P. Hainsworth et al. Risk factors for retinopathy in type 1 diabetes: The DCCT/EDIC Study. Diabetes Care. (2019)
  • 13. Diabetes Control Complications Trial Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. (1993)
  • 14. American Diabetes Association. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024. Diabetes Care (2024)
  • 15. L.E. Graves et al. Management of diabetes complications in youth. Ther Adv Endocrinol Metab. (2019)
  • 16. S. Tesfaye et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. (2010)
  • 17. R. Franceschi et al. A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 diabetes. Acta Diabetol. (2022)
  • 18. L. Nattero-Chávez et al. Point-of-care sural nerve conduction could predict the presence of cardiovascular autonomic neuropathy in type 1 diabetes mellitus. J Diabetes Investig.(2022)
  • 19. M. Jaiswal et al. Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study. Diabetes Care.(2017)
  • 20. R. Freeman. Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy. Curr Diab Rep. (2009)
Fuente de los datos: Dialnet